# Tannin Specific Natural Extract for COVID-19 Infection

> **NCT04403646** · NA · TERMINATED · sponsor: **Hospital de Clinicas José de San Martín** · enrollment: 124 (actual)

## Conditions studied

- COVID-19
- SARS-CoV 2
- Coronavirus Infection

## Interventions

- **DIETARY_SUPPLEMENT:** ARBOX
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT04403646
- **Lead sponsor:** Hospital de Clinicas José de San Martín
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-12
- **Primary completion:** 2020-10-20
- **Final completion:** 2020-11-01
- **Target enrollment:** 124 (ACTUAL)
- **Why stopped:** low rate of covid patients
- **Last updated:** 2020-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403646, "Tannin Specific Natural Extract for COVID-19 Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04403646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*